We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A doctor holding a patients hands.
Product News

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

Revvity, Inc. (NYSE: RVTY), announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone.
Three researchers working in a lab.
Product News

MOBILion Systems Announces the 100th Peer-Reviewed Publication Featuring Its Separations Technology Platform

MOBILion Systems, Inc., announced that as of December 2024, its foundational Structures for Lossless Ion Manipulation (SLIM) platform technology reached the milestone of being highlighted in 100 peer-reviewed publications.
A scientist pipetting into a test tube.
Product News

Geneoscopy Closes $105M in Series C Funding Round To Power Next-Generation of Gastrointestinal Diagnostic Tests

Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease.
A gad chromatographer.
Product News

Bio-Rad Extends Range of Foresight Pro Prepacked Chromatography Columns for Biotherapeutic Production

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the launch of Foresight™ Pro 45 cm inner diameter (ID) chromatography columns, designed to support downstream process-scale chromatography applications.
EZ-Spread™ Plating Beads streamline cell plating with uniform distribution and increased colony formation.
Product News

Optimized Plating of Bacterial and Yeast Cells on Standard Agar Plates

EZ-Spread™ Plating Beads from AMSBIO allow you to spread bacterial and yeast cells across the surface of an agar plate in just seconds.
Two scientists looking at a laptop screen.
Product News

New Optimer Contract To Develop Bioanalytical Tools for RNA Therapy

Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces the signing of a new development contract with a rare disease biopharmaceutical company.
Advertisement